Multiple signaling cascades are differentially involved in gene induction by double stranded RNA in interferon-α-primed cells

被引:17
作者
Harcourt, JL
Offermann, MK
机构
[1] Emory Univ, Winship Canc Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Program Biochem Cellular & Dev Biol, Atlanta, GA 30322 USA
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2001年 / 268卷 / 05期
关键词
double stranded RNA; P38; MAPK; IL-6; interferon; Erk;
D O I
10.1046/j.1432-1327.2001.02003.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Priming with interfon (IFN)alpha enhanced the ability of the synthetic double-stranded RNA polyriboinosinic acid: polyribocytidilic acid (pI:C), but not interleukin-1 beta, to activate both p38 mitogen-activated kinase (MAPK) and extracellular signal-regulated kinase (ERK) signaling cascades. Activation by pI:C in IFN alpha -primed cells was delayed compared to activation with interleukin-1 beta, and this delay was followed by high, sustained activation of p38 MAPK and a modest elevation of ERK activation. Pharmacologic inhibition of either the ERK or the p38 MAPK pathway, using U0126 and SB203580, respectively, reduced interleukin-6 protein induction by at least 70%, and combined inhibition of both pathways fully blocked interleukin-6 protein expression and reduced interleukin-6 mRNA induction by more than 80%. In contrast, induction of double-stranded RNA-activated protein kinase (PKR) mRNA and protein by IFN alpha and/or pI:C was minimally affected by either inhibitor. Induction of interferon-regulatory factor-1 (IRF-1) by pI:C in IFN alpha primed cells was profoundly inhibited by U0126 but not by SB203580. Thus, IFN alpha priming enhances activation of p38 MAPK and ERK pathways by pI:C but not by interleukin-1 beta, thereby enhancing the expression of some, but not all, genes that are induced by pI:C.
引用
收藏
页码:1373 / 1381
页数:9
相关论文
共 65 条
  • [1] SEQUENCE IDENTIFICATION OF 2,375 HUMAN BRAIN GENES
    ADAMS, MD
    DUBNICK, M
    KERLAVAGE, AR
    MORENO, R
    KELLEY, JM
    UTTERBACK, TR
    NAGLE, JW
    FIELDS, C
    VENTER, JC
    [J]. NATURE, 1992, 355 (6361) : 632 - 634
  • [2] BACON K, 1990, Cytokine, V2, P100, DOI 10.1016/1043-4666(90)90003-C
  • [3] STRUCTURE OF 2 FORMS OF THE INTERFERON-INDUCED (2-'-5-') OLIGO-A SYNTHETASE OF HUMAN-CELLS BASED ON CDNAS AND GENE-SEQUENCES
    BENECH, P
    MORY, Y
    REVEL, M
    CHEBATH, J
    [J]. EMBO JOURNAL, 1985, 4 (09) : 2249 - 2256
  • [4] PKR - A protein kinase regulated by double-stranded RNA
    Clemens, MJ
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (07) : 945 - 949
  • [5] SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1
    CUENDA, A
    ROUSE, J
    DOZA, YN
    MEIER, R
    COHEN, P
    GALLAGHER, TF
    YOUNG, PR
    LEE, JC
    [J]. FEBS LETTERS, 1995, 364 (02) : 229 - 233
  • [6] Specificity and mechanism of action of some commonly used protein kinase inhibitors
    Davies, SP
    Reddy, H
    Caivano, M
    Cohen, P
    [J]. BIOCHEMICAL JOURNAL, 2000, 351 (351) : 95 - 105
  • [7] MAPKS - NEW JNK EXPANDS THE GROUP
    DAVIS, RJ
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (11) : 470 - 473
  • [8] Effects of varying lengths of double-stranded RNA on binding and activation of 2'-5'-oligoadenylate synthetase
    Desai, SY
    Sen, GC
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (09) : 531 - 536
  • [9] New insights into the control of MAP kinase pathways
    English, J
    Pearson, G
    Wilsbacher, J
    Swantek, J
    Karandikar, M
    Xu, SC
    Cobb, MH
    [J]. EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) : 255 - 270
  • [10] Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SE 203580
    Eyers, PA
    van den Ijssel, P
    Quinlan, RA
    Goedert, M
    Cohen, P
    [J]. FEBS LETTERS, 1999, 451 (02) : 191 - 196